Latest stories on SMMT
Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data
Yahoo Finance58 · neutralproduct/pr
Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference | SMMT Stock News
StockTitan53 · neutralproduct/pr
Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC
Yahoo Top77 · bullishproduct/pr
Summit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress - Slideshow
Seeking Alpha58 · neutralproduct/pr
Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments
Yahoo Top58 · neutralanalyst
Summit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress Transcript
Seeking Alpha58 · neutralproduct/pr
Summit Therapeutics Reports Strong Interim Ivonescimab Phase II Data
TipRanks67 · bullishproduct/pr
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026 | SMMT Stock News
StockTitan77 · bullishproduct/pr
Summit downgraded at H.C. Wainwright after Merck data for sac-TMT
Seeking Alpha33 · bearishanalyst
3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22
TipRanks61 · neutralanalyst
H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT)
Yahoo Finance33 · bearishanalyst